Eptifibatide Injection, Solution
Product Images NDC 71288-412

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Eptifibatide (NDC 71288-412). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Ept04 0004 01)

Chemical structure of Eptifibatide, the active ingredient in the drug product Eptifibatide injection solution by Meitheal Pharmaceuticals Inc. The structure shows the molecular arrangement of atoms specific to Eptifibatide.*

FDA Label Image

Figure 1 (Ept04 0004 02)

A line graph depicting the percent of patients with events over a 30-day period, comparing treatment with Eptifibatide (solid line) and Placebo (dashed line). The x-axis represents time in days, and the y-axis shows the percent of patients with events, increasing over time for both groups.*

FDA Label Image

Principal Display Panel – Eptifibatide Injection, 20 mg Per 10 mL Container Label (Ept04 0004 03 V2)

Label for Eptifibatide Injection, 20 mg per 10 mL (2 mg per mL) single-dose vial for intravenous use. The label includes storage instructions, lot and expiration placeholders, and identifies Meitheal Pharmaceuticals Inc. as the manufacturer. It specifies the product is prescription-only and made in China.*

FDA Label Image

Principal Display Panel – Eptifibatide Injection, 20 mg Per 10 mL Carton (Ept04 0004 04 V2)

Packaging label for Eptifibatide Injection, 20 mg per 10 mL (2 mg per mL) intravenous solution. The label indicates a single-dose vial for weight-adjusted bolus dosing. It includes storage instructions, manufacturer details (Meitheal Pharmaceuticals Inc.), and regulatory information including barcode and lot details. The design features a predominantly pink and white color scheme with the brand and dosage prominently displayed.*

FDA Label Image

Principal Display Panel – Eptifibatide Injection, 75 mg Per 100 mL Container Label (Ept04 0004 05 V3)

Eptifibatide Injection label for a 100 mL single-dose vial containing a solution for intravenous use. The concentration is 75 mg per 100 mL (0.75 mg per mL). The label includes storage instructions, formulation details, and warnings about preservative-free contents. Manufactured by Meitheal Pharmaceuticals Inc.*

FDA Label Image

Principal Display Panel – Eptifibatide Injection, 75 mg Per 100 mL Carton (Ept04 0004 06 V2)

Packaging label for Eptifibatide Injection 75 mg per 100 mL (0.75 mg per mL) solution for intravenous use. The label states it is for intravenous use only, in a single 100 mL single-dose vial intended for weight-adjusted infusion. The labeler is Meitheal Pharmaceuticals Inc. Storage and usage instructions are included, along with a barcode and spaces for dispensing pharmacist to record discard date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.